FDA inspection
U.S. Food and Drug Administration (FDA) Institutional Review Board (IRB): FDA inspection ending May 8, 2024
FDA inspection 1238162 · No Action Indicated (NAI) · Silver Spring, MD
Key facts
| Inspection ID | 1238162 |
|---|---|
| Firm | U.S. Food and Drug Administration (FDA) Institutional Review Board (IRB) |
| FEI number | 1120137 |
| Address | 10903 New Hampshire Ave |
| City | Silver Spring |
| State | MD |
| ZIP | 20993 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | May 8, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data